ASH1L: A Potential Drug Target and Biomarker (G55870)

Target Name: ASH1L

NCBI ID: G55870

ASH1L

ASH1L: A Potential Drug Target and Biomarker

ASH1L (absent, small, or homeotic-like) is a gene that has been identified in various organisms, including humans. ASH1L plays a crucial role in the development and maintenance of tissues, and it has been associated with various diseases, including cancer, neurodegenerative diseases, and developmental disorders.

The ASH1L gene has been shown to be involved in the regulation of cell growth, differentiation, and survival. It has been shown to promote the growth and survival of cancer cells, and it has also been linked to the development of neurodegenerative diseases, such as Alzheimer's and Parkinson's diseases.

In addition to its potential role in disease, ASH1L has also been identified as a potential drug target. By targeting the ASH1L gene, researchers may be able to develop new treatments for a variety of conditions.

Drug Targets and ASH1L

ASH1L has been identified as a potential drug target due to its involvement in the regulation of cell growth and survival. It has been shown to promote the growth and survival of cancer cells, which makes it an attractive target for cancer treatments.

In addition to its role in cancer, ASH1L has also been linked to the development of neurodegenerative diseases. ASH1L has been shown to promote the growth and survival of neurodegenerative disease-related cells, which may make it a potential target for treatments for these conditions.

Biomarkers

ASH1L has also been identified as a potential biomarker for several diseases, including cancer and neurodegenerative diseases. ASH1L has been shown to be expressed in a variety of tissues and cells, including cancer cells, neurons, and glial cells in neurodegenerative diseases.

This suggests that ASH1L may be a useful biomarker for the diagnosis and treatment of these conditions. It also suggests that ASH1L may be a useful target for developing new treatments for these conditions.

Conclusion

In conclusion, ASH1L is a gene that has been identified in various organisms, including humans. It plays a crucial role in the development and maintenance of tissues and has been associated with various diseases, including cancer and neurodegenerative diseases.

ASH1L has also been shown to be involved in the regulation of cell growth and survival, making it a potential drug target. Furthermore, ASH1L has also been identified as a potential biomarker for several diseases, including cancer and neurodegenerative diseases.

These findings suggest that ASH1L may be a valuable target for the development of new treatments for a variety of conditions. Further research is needed to fully understand the role of ASH1L in disease and to develop effective treatments.

Protein Name: ASH1 Like Histone Lysine Methyltransferase

Functions: Histone methyltransferase specifically trimethylating 'Lys-36' of histone H3 forming H3K36me3 (PubMed:21239497). Also monomethylates 'Lys-9' of histone H3 (H3K9me1) in vitro (By similarity). The physiological significance of the H3K9me1 activity is unclear (By similarity)

The "ASH1L Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ASH1L comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets